Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Scoliosis Management Market Outlook (2022 to 2032)

The scoliosis management market is likely to record a CAGR of 3.9% during the forecast period, up from US$ 2,942.8 Million in 2022 to reach a valuation of US$ 4,489.0 Million by 2032.

The high prevalence of scoliosis, the high adoption rate of braces, and the progress of technology with tracking devices that can monitor the health of the patient are the primary factors driving the growth of the scoliosis management market. The demand for scoliosis management is also anticipated to be driven by the growing demand for minimally-invasive therapies.

As per the scoliosis management market study, the disease affects both sexes, but the progression of the curve is eight times greater in women than in men. However, as patients must wear the device for 22-23 hours a day, it stiffens their bodies, resulting in skin irritation and rashes. Additionally, it puts pressure on the chest and abdomen, which can lead to breathing difficulties and a reduction in oxygen delivery to the lungs. This is likely to hamper the growth of the scoliosis management market.

It is projected that the scoliosis management market would expand over the forecast period in addition to lower prices for braces, more public awareness is likely to boost the adoption of scoliosis management over during the forecast period.

Attributes Details
Estimated Market Value (2022) US$ 2,942.8 Million
Forecasted Market Value (2032) US$ 4,489.0 Million
CAGR (2022 to 2032) 3.9%

Among the key trends in the scoliosis management market, the progression of innovation with GPS beacons to screen patients are likely to remain dominant during the forecast period. The growth momentum of the scoliosis management market is further prompted by the high prevalence of the disease, advancements in the latest technologies, and rising support from governments. In addition, the scoliosis management market needs to be driven by an increasing need for therapies that do not involve invasive surgery.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How will the Scoliosis Management Market Grow in the Future?

The scoliosis management market analysis indicates that there has been a significant increase in the number of people diagnosed with scoliosis around the world. Scoliosis affects an estimated 2-3 percent of the population in the United States alone, with an estimated six to nine million persons affected by the condition. Nearly 600,000 patients have visited private institutions, over 30,000 adolescents wear braces, and approximately 38,000 people have undergone spinal fusion surgery in the United States since 2010.

The scoliosis management market expansion is being fuelled by multiple factors high cost of therapy or procedures, can limit the scoliosis management market expansion. The shortage of competent specialists, poor payment regulations, and a lack of knowledge about the illness and available treatment choices are all limiting the overall demand for scoliosis management.

How is the Scoliosis Management Market Segmented?

The TLSO product segment of the scoliosis management market is predicted to grow at a CAGR of 3.8 percent during the projection period, a remarkable achievement. The scoliosis management market is divided into three sections based on age groups infantile, adolescent, and young adult.

The entire scoliosis management market is likely to be dominated by the adolescent age group during the forecast period, with revenue expected to reach US$ 3,494.9 Million by 2028. Hospital pharmacies, retail pharmacies, and internet sales make up the three major segments of the global scoliosis management industry.

The online sales category of the scoliosis management market is predicted to develop at the fastest rate over the projection period in terms of distribution channels.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Regional Analysis

What is the Europe and North American Growth Outlook for the Scoliosis Management Market?

Over the course of the forecast period, it is anticipated that the scoliosis management market is expected to be led by North America, with a share of 39% in 2022.

After North America, Europe is the second-largest market with a scoliosis management market. The European scoliosis management market is likely to hold a market share of 23% by the end of 2022. As a result of the high adoption rate of braces in Western Europe, there has been a recent surge in the adoption of scoliosis management products. Over the course of the period covered by this forecast, the revenue growth of the scoliosis management market in Western Europe is anticipated to be boosted by an increase in demand for non-invasive treatments.

The increasing prevalence of idiopathic scoliosis and the support provided by governments in the form of funding and awareness initiatives are likely to be the primary drivers of growth in the scoliosis management market throughout the forecast period in Europe. The British Scoliosis Research Foundation provides research grants to qualified professionals for the purpose of conducting research in the field of scoliosis in the United Kingdom. As a result, it is anticipated that the development of treatment options for scoliosis in Europe is expected to flourish and the demand for scoliosis management is expected to improve.

How is Europe Performing in the Scoliosis Management Market?

With an increase in healthcare spending and an abundance of management alternatives, Asia-Pacific excluding Japan is expected to expand at the quickest CAGR during this projected period. In addition, the scoliosis management market is growing as a result of the region's constant technical advancements and new introductions. A shortage of qualified healthcare workers as well as low per capita healthcare spending in these regions, along with a lack of knowledge about the disease, are projected to keep the growth momentum in regions such as Latin America and the Middle East, and Africa during the projection year.

Start-up Ecosystem

How is the Start-up Ecosystem in the Scoliosis Management Market?

New innovations are leading the development of the scoliosis management market. Market players are increasingly focusing on devising more accessible products. The scoliosis management market is growing rapidly due to high research and development by companies.

As per the scoliosis management market study, a new spinal fusion technology product and the solution were introduced in the United States by Alphatec Spine Inc., a medical device company based in California that designs, develops, manufactures, and markets spinal fusion technology products and solutions. The new system is called the Arsenal Deformity Adolescent Idiopathic Scoliosis (AIS) System.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

How is the Competitive Landscape in the Scoliosis Management Market?

In order to maintain and increase their significant market shares in the scoliosis management market, market vendors are concentrating their efforts on the development of new technologies. By way of illustration, 3D Systems introduced its 3D-printed bespoke braces for the treatment of scoliosis. This is leading the global scoliosis management market.

Recent Developments

A significant number of companies that are active in the global scoliosis management market are concentrating their efforts on forming collaborations and partnerships with regional distributors and retailers in order to strengthen their position in international markets. Companies can improve their product visibility across a wider range of regions as a result of these collaborations and partnerships. Similarly, the companies that are currently in the scoliosis management market are placing a significant emphasis on investing in product innovation in order to bolster their presence in markets all over the world.

Key Players

  • Boston Orthotics & Prosthetics
  • Chaneco
  • Original Bending Brace
  • orthotech
  • Wilmington Orthotics & Prosthetics, Inc.
  • Lawall Prosthetics and Orthotics
  • Horton's Orthotics & Prosthetics
  • Aspen Medical Products
  • UNYQ
  • C H Martin Company
  • Optec USA, Inc.
  • Spinal Technology, Inc.
  • Ortholutions GmbH & Co.
  • KG Wellinks, Inc.
  • Pro-Tech Orthopedics

Report Scope

Report Attribute Details
Growth rate CAGR of 3.9% from 2022 to 2032
The base year for estimation 2021
Historical data 2016 to 2021
Forecast period 2022 to 2032
Quantitative units Revenue in USD billion and CAGR from 2022 to 2032
Report Coverage Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,
Segments Covered Disease, Age, Product, Distribution Channels, Region
Regional scope North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia, and New Zealand
Country scope United States of America; Canada; Mexico; Germany; United Kingdom; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled Boston Orthotics & Prosthetics, Chaneco, Original Bending Brace, Orthotech, Trulife, L.A. Brace, Össur, DJO, LLC, Wilmington Orthotics & Prosthetics, Inc., Lawall Prosthetics and Orthotics, Horton's Orthotics & Prosthetics, Aspen Medical Products, UNYQ, C H Martin Company, Optec USA, Inc., Spinal Technology, Inc., Ortholutions GmbH & Co. KG, Wellinks, Inc., and Pro-Tech Orthopedics.
Customization scope Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Avail customized purchase options to meet your exact research needs.

Key Segments

By Disease Type:

  • Infantile Idiopathic Scoliosis
  • Juvenile Idiopathic Scoliosis
  • Adolescent Idiopathic Scoliosis

By Age:

  • Pediatric
  • Adult

By Product Type:

  • Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
  • Thoracolumbosacral Orthosis (TLSO)
  • Lumbosacral Orthosis (LSO)

By Distribution Channels:

  • Hospitals & Clinics
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Middle East and Africa (MEA)
  • Europe

Frequently Asked Questions

What is the Growth Outlook for the Scoliosis Management Market?

The scoliosis management market is likely to register a CAGR of 3.9% during the forecast period.

What is the Future of the Scoliosis Management Market?

As per the analysis, the scoliosis management market share is likely to be US$ 4,489.0 Million by 2032.

Which is the Key Driver in the Scoliosis Management Market?

The constant progression of technology is the key driver in the industry.

Table of Content

1. Executive Summary | Scoliosis Management Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute Opportunity Analysis

5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Disease Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Disease Type, 2017 to 2021

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Type, 2022 to 2032

        5.3.1. Infantile Idiopathic Scoliosis

        5.3.2. Juvenile Idiopathic Scoliosis

        5.3.3. Adolescent Idiopathic Scoliosis

    5.4. Y-o-Y Growth Trend Analysis By Disease Type, 2017 to 2021

    5.5. Absolute Opportunity Analysis By Disease Type, 2022 to 2032

6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Age

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Age, 2017 to 2021

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Age, 2022 to 2032

        6.3.1. Pediatric

        6.3.2. Adult

    6.4. Y-o-Y Growth Trend Analysis By Age, 2017 to 2021

    6.5. Absolute Opportunity Analysis By Age, 2022 to 2032

7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032

        7.3.1. Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)

        7.3.2. Thoracolumbosacral Orthosis (TLSO)

        7.3.3. Lumbosacral Orthosis (LSO)

    7.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021

    7.5. Absolute Opportunity Analysis By Product Type, 2022 to 2032

8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channels

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channels, 2017 to 2021

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channels, 2022 to 2032

        8.3.1. Hospitals & Clinics

        8.3.2. Retail Pharmacies

        8.3.3. Online Pharmacies

    8.4. Y-o-Y Growth Trend Analysis By Distribution Channels, 2017 to 2021

    8.5. Absolute Opportunity Analysis By Distribution Channels, 2022 to 2032

9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. United States of America

            10.2.1.2. Canada

        10.2.2. By Disease Type

        10.2.3. By Age

        10.2.4. By Product Type

        10.2.5. By Distribution Channels

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Disease Type

        10.3.3. By Age

        10.3.4. By Product Type

        10.3.5. By Distribution Channels

    10.4. Key Takeaways

11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Disease Type

        11.2.3. By Age

        11.2.4. By Product Type

        11.2.5. By Distribution Channels

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Disease Type

        11.3.3. By Age

        11.3.4. By Product Type

        11.3.5. By Distribution Channels

    11.4. Key Takeaways

12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. United Kingdom

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Disease Type

        12.2.3. By Age

        12.2.4. By Product Type

        12.2.5. By Distribution Channels

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Disease Type

        12.3.3. By Age

        12.3.4. By Product Type

        12.3.5. By Distribution Channels

    12.4. Key Takeaways

13. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

            13.2.1.4. India

            13.2.1.5. Malaysia

            13.2.1.6. Singapore

            13.2.1.7. Australia

            13.2.1.8. New Zealand

            13.2.1.9. Rest of Asia-Pacific (APAC)

        13.2.2. By Disease Type

        13.2.3. By Age

        13.2.4. By Product Type

        13.2.5. By Distribution Channels

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Disease Type

        13.3.3. By Age

        13.3.4. By Product Type

        13.3.5. By Distribution Channels

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of Middle East and Africa

        14.2.2. By Disease Type

        14.2.3. By Age

        14.2.4. By Product Type

        14.2.5. By Distribution Channels

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Disease Type

        14.3.3. By Age

        14.3.4. By Product Type

        14.3.5. By Distribution Channels

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. United States of America

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Disease Type

            15.1.2.2. By Age

            15.1.2.3. By Product Type

            15.1.2.4. By Distribution Channels

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Disease Type

            15.2.2.2. By Age

            15.2.2.3. By Product Type

            15.2.2.4. By Distribution Channels

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Disease Type

            15.3.2.2. By Age

            15.3.2.3. By Product Type

            15.3.2.4. By Distribution Channels

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Disease Type

            15.4.2.2. By Age

            15.4.2.3. By Product Type

            15.4.2.4. By Distribution Channels

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Disease Type

            15.5.2.2. By Age

            15.5.2.3. By Product Type

            15.5.2.4. By Distribution Channels

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Disease Type

            15.6.2.2. By Age

            15.6.2.3. By Product Type

            15.6.2.4. By Distribution Channels

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Disease Type

            15.7.2.2. By Age

            15.7.2.3. By Product Type

            15.7.2.4. By Distribution Channels

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Disease Type

            15.8.2.2. By Age

            15.8.2.3. By Product Type

            15.8.2.4. By Distribution Channels

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Disease Type

            15.9.2.2. By Age

            15.9.2.3. By Product Type

            15.9.2.4. By Distribution Channels

    15.10. China

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Disease Type

            15.10.2.2. By Age

            15.10.2.3. By Product Type

            15.10.2.4. By Distribution Channels

    15.11. Japan

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Disease Type

            15.11.2.2. By Age

            15.11.2.3. By Product Type

            15.11.2.4. By Distribution Channels

    15.12. South Korea

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Disease Type

            15.12.2.2. By Age

            15.12.2.3. By Product Type

            15.12.2.4. By Distribution Channels

    15.13. Malaysia

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Disease Type

            15.13.2.2. By Age

            15.13.2.3. By Product Type

            15.13.2.4. By Distribution Channels

    15.14. Singapore

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Disease Type

            15.14.2.2. By Age

            15.14.2.3. By Product Type

            15.14.2.4. By Distribution Channels

    15.15. Australia

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Disease Type

            15.15.2.2. By Age

            15.15.2.3. By Product Type

            15.15.2.4. By Distribution Channels

    15.16. New Zealand

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Disease Type

            15.16.2.2. By Age

            15.16.2.3. By Product Type

            15.16.2.4. By Distribution Channels

    15.17. GCC Countries

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Disease Type

            15.17.2.2. By Age

            15.17.2.3. By Product Type

            15.17.2.4. By Distribution Channels

    15.18. South Africa

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Disease Type

            15.18.2.2. By Age

            15.18.2.3. By Product Type

            15.18.2.4. By Distribution Channels

    15.19. Israel

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Disease Type

            15.19.2.2. By Age

            15.19.2.3. By Product Type

            15.19.2.4. By Distribution Channels

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Disease Type

        16.3.3. By Age

        16.3.4. By Product Type

        16.3.5. By Distribution Channels

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Boston Orthotics & Prosthetics

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Chaneco

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Original Bending Brace

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Orthotech

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Trulife

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. L.A. Brace

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Össur

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Wilmington Orthotics & Prosthetics Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Lawall Prosthetics and Orthotics

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Horton's Orthotics & Prosthetics

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032

Table 2: Global Market Value (US$ Million) Forecast by Disease Type, 2017 to 2032

Table 3: Global Market Value (US$ Million) Forecast by Age, 2017 to 2032

Table 4: Global Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 5: Global Market Value (US$ Million) Forecast by Distribution Channels, 2017 to 2032

Table 6: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 7: North America Market Value (US$ Million) Forecast by Disease Type, 2017 to 2032

Table 8: North America Market Value (US$ Million) Forecast by Age, 2017 to 2032

Table 9: North America Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 10: North America Market Value (US$ Million) Forecast by Distribution Channels, 2017 to 2032

Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 12: Latin America Market Value (US$ Million) Forecast by Disease Type, 2017 to 2032

Table 13: Latin America Market Value (US$ Million) Forecast by Age, 2017 to 2032

Table 14: Latin America Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 15: Latin America Market Value (US$ Million) Forecast by Distribution Channels, 2017 to 2032

Table 16: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 17: Europe Market Value (US$ Million) Forecast by Disease Type, 2017 to 2032

Table 18: Europe Market Value (US$ Million) Forecast by Age, 2017 to 2032

Table 19: Europe Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 20: Europe Market Value (US$ Million) Forecast by Distribution Channels, 2017 to 2032

Table 21: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 22: Asia Pacific Market Value (US$ Million) Forecast by Disease Type, 2017 to 2032

Table 23: Asia Pacific Market Value (US$ Million) Forecast by Age, 2017 to 2032

Table 24: Asia Pacific Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 25: Asia Pacific Market Value (US$ Million) Forecast by Distribution Channels, 2017 to 2032

Table 26: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 27: Middle East and Africa Market Value (US$ Million) Forecast by Disease Type, 2017 to 2032

Table 28: Middle East and Africa Market Value (US$ Million) Forecast by Age, 2017 to 2032

Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channels, 2017 to 2032
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Disease Type, 2022 to 2032

Figure 2: Global Market Value (US$ Million) by Age, 2022 to 2032

Figure 3: Global Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 4: Global Market Value (US$ Million) by Distribution Channels, 2022 to 2032

Figure 5: Global Market Value (US$ Million) by Region, 2022 to 2032

Figure 6: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032

Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032

Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032

Figure 9: Global Market Value (US$ Million) Analysis by Disease Type, 2017 to 2032

Figure 10: Global Market Value Share (%) and BPS Analysis by Disease Type, 2022 to 2032

Figure 11: Global Market Y-o-Y Growth (%) Projections by Disease Type, 2022 to 2032

Figure 12: Global Market Value (US$ Million) Analysis by Age, 2017 to 2032

Figure 13: Global Market Value Share (%) and BPS Analysis by Age, 2022 to 2032

Figure 14: Global Market Y-o-Y Growth (%) Projections by Age, 2022 to 2032

Figure 15: Global Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 16: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 17: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 18: Global Market Value (US$ Million) Analysis by Distribution Channels, 2017 to 2032

Figure 19: Global Market Value Share (%) and BPS Analysis by Distribution Channels, 2022 to 2032

Figure 20: Global Market Y-o-Y Growth (%) Projections by Distribution Channels, 2022 to 2032

Figure 21: Global Market Attractiveness by Disease Type, 2022 to 2032

Figure 22: Global Market Attractiveness by Age, 2022 to 2032

Figure 23: Global Market Attractiveness by Product Type, 2022 to 2032

Figure 24: Global Market Attractiveness by Distribution Channels, 2022 to 2032

Figure 25: Global Market Attractiveness by Region, 2022 to 2032

Figure 26: North America Market Value (US$ Million) by Disease Type, 2022 to 2032

Figure 27: North America Market Value (US$ Million) by Age, 2022 to 2032

Figure 28: North America Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 29: North America Market Value (US$ Million) by Distribution Channels, 2022 to 2032

Figure 30: North America Market Value (US$ Million) by Country, 2022 to 2032

Figure 31: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 34: North America Market Value (US$ Million) Analysis by Disease Type, 2017 to 2032

Figure 35: North America Market Value Share (%) and BPS Analysis by Disease Type, 2022 to 2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by Disease Type, 2022 to 2032

Figure 37: North America Market Value (US$ Million) Analysis by Age, 2017 to 2032

Figure 38: North America Market Value Share (%) and BPS Analysis by Age, 2022 to 2032

Figure 39: North America Market Y-o-Y Growth (%) Projections by Age, 2022 to 2032

Figure 40: North America Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 41: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 42: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 43: North America Market Value (US$ Million) Analysis by Distribution Channels, 2017 to 2032

Figure 44: North America Market Value Share (%) and BPS Analysis by Distribution Channels, 2022 to 2032

Figure 45: North America Market Y-o-Y Growth (%) Projections by Distribution Channels, 2022 to 2032

Figure 46: North America Market Attractiveness by Disease Type, 2022 to 2032

Figure 47: North America Market Attractiveness by Age, 2022 to 2032

Figure 48: North America Market Attractiveness by Product Type, 2022 to 2032

Figure 49: North America Market Attractiveness by Distribution Channels, 2022 to 2032

Figure 50: North America Market Attractiveness by Country, 2022 to 2032

Figure 51: Latin America Market Value (US$ Million) by Disease Type, 2022 to 2032

Figure 52: Latin America Market Value (US$ Million) by Age, 2022 to 2032

Figure 53: Latin America Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 54: Latin America Market Value (US$ Million) by Distribution Channels, 2022 to 2032

Figure 55: Latin America Market Value (US$ Million) by Country, 2022 to 2032

Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 59: Latin America Market Value (US$ Million) Analysis by Disease Type, 2017 to 2032

Figure 60: Latin America Market Value Share (%) and BPS Analysis by Disease Type, 2022 to 2032

Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Disease Type, 2022 to 2032

Figure 62: Latin America Market Value (US$ Million) Analysis by Age, 2017 to 2032

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Age, 2022 to 2032

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Age, 2022 to 2032

Figure 65: Latin America Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 66: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 68: Latin America Market Value (US$ Million) Analysis by Distribution Channels, 2017 to 2032

Figure 69: Latin America Market Value Share (%) and BPS Analysis by Distribution Channels, 2022 to 2032

Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channels, 2022 to 2032

Figure 71: Latin America Market Attractiveness by Disease Type, 2022 to 2032

Figure 72: Latin America Market Attractiveness by Age, 2022 to 2032

Figure 73: Latin America Market Attractiveness by Product Type, 2022 to 2032

Figure 74: Latin America Market Attractiveness by Distribution Channels, 2022 to 2032

Figure 75: Latin America Market Attractiveness by Country, 2022 to 2032

Figure 76: Europe Market Value (US$ Million) by Disease Type, 2022 to 2032

Figure 77: Europe Market Value (US$ Million) by Age, 2022 to 2032

Figure 78: Europe Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 79: Europe Market Value (US$ Million) by Distribution Channels, 2022 to 2032

Figure 80: Europe Market Value (US$ Million) by Country, 2022 to 2032

Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 84: Europe Market Value (US$ Million) Analysis by Disease Type, 2017 to 2032

Figure 85: Europe Market Value Share (%) and BPS Analysis by Disease Type, 2022 to 2032

Figure 86: Europe Market Y-o-Y Growth (%) Projections by Disease Type, 2022 to 2032

Figure 87: Europe Market Value (US$ Million) Analysis by Age, 2017 to 2032

Figure 88: Europe Market Value Share (%) and BPS Analysis by Age, 2022 to 2032

Figure 89: Europe Market Y-o-Y Growth (%) Projections by Age, 2022 to 2032

Figure 90: Europe Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 91: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 92: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 93: Europe Market Value (US$ Million) Analysis by Distribution Channels, 2017 to 2032

Figure 94: Europe Market Value Share (%) and BPS Analysis by Distribution Channels, 2022 to 2032

Figure 95: Europe Market Y-o-Y Growth (%) Projections by Distribution Channels, 2022 to 2032

Figure 96: Europe Market Attractiveness by Disease Type, 2022 to 2032

Figure 97: Europe Market Attractiveness by Age, 2022 to 2032

Figure 98: Europe Market Attractiveness by Product Type, 2022 to 2032

Figure 99: Europe Market Attractiveness by Distribution Channels, 2022 to 2032

Figure 100: Europe Market Attractiveness by Country, 2022 to 2032

Figure 101: Asia Pacific Market Value (US$ Million) by Disease Type, 2022 to 2032

Figure 102: Asia Pacific Market Value (US$ Million) by Age, 2022 to 2032

Figure 103: Asia Pacific Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 104: Asia Pacific Market Value (US$ Million) by Distribution Channels, 2022 to 2032

Figure 105: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032

Figure 106: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Disease Type, 2017 to 2032

Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Disease Type, 2022 to 2032

Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Disease Type, 2022 to 2032

Figure 112: Asia Pacific Market Value (US$ Million) Analysis by Age, 2017 to 2032

Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Age, 2022 to 2032

Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Age, 2022 to 2032

Figure 115: Asia Pacific Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 118: Asia Pacific Market Value (US$ Million) Analysis by Distribution Channels, 2017 to 2032

Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channels, 2022 to 2032

Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channels, 2022 to 2032

Figure 121: Asia Pacific Market Attractiveness by Disease Type, 2022 to 2032

Figure 122: Asia Pacific Market Attractiveness by Age, 2022 to 2032

Figure 123: Asia Pacific Market Attractiveness by Product Type, 2022 to 2032

Figure 124: Asia Pacific Market Attractiveness by Distribution Channels, 2022 to 2032

Figure 125: Asia Pacific Market Attractiveness by Country, 2022 to 2032

Figure 126: Middle East and Africa Market Value (US$ Million) by Disease Type, 2022 to 2032

Figure 127: Middle East and Africa Market Value (US$ Million) by Age, 2022 to 2032

Figure 128: Middle East and Africa Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 129: Middle East and Africa Market Value (US$ Million) by Distribution Channels, 2022 to 2032

Figure 130: Middle East and Africa Market Value (US$ Million) by Country, 2022 to 2032

Figure 131: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Disease Type, 2017 to 2032

Figure 135: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Type, 2022 to 2032

Figure 136: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Type, 2022 to 2032

Figure 137: Middle East and Africa Market Value (US$ Million) Analysis by Age, 2017 to 2032

Figure 138: Middle East and Africa Market Value Share (%) and BPS Analysis by Age, 2022 to 2032

Figure 139: Middle East and Africa Market Y-o-Y Growth (%) Projections by Age, 2022 to 2032

Figure 140: Middle East and Africa Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 141: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 142: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 143: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channels, 2017 to 2032

Figure 144: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channels, 2022 to 2032

Figure 145: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channels, 2022 to 2032

Figure 146: Middle East and Africa Market Attractiveness by Disease Type, 2022 to 2032

Figure 147: Middle East and Africa Market Attractiveness by Age, 2022 to 2032

Figure 148: Middle East and Africa Market Attractiveness by Product Type, 2022 to 2032

Figure 149: Middle East and Africa Market Attractiveness by Distribution Channels, 2022 to 2032

Figure 150: Middle East and Africa Market Attractiveness by Country, 2022 to 2032

Recommendations

Healthcare

Spine Biologics Market

Published : November 2022

Explore Healthcare Insights

View Reports

Scoliosis Management Market